Literature DB >> 8609214

Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.

P D Ponath1, S Qin, D J Ringler, I Clark-Lewis, J Wang, N Kassam, H Smith, X Shi, J A Gonzalo, W Newman, J C Gutierrez-Ramos, C R Mackay.   

Abstract

The CC chemokine eotaxin, identified in guinea pigs and also recently in mice, may be a key element for the selective recruitment of eosinophils to certain inflamed tissues. Using a partial mouse eotaxin CDNA probe, the human eotaxin gene was cloned and found to be 61.8 and 63.2% identical at the amino acid level to guinea pig and mouse eotaxin. Human eotaxin protein was a strong and specific eosinophil chemoattractant in vitro and was an effective eosinophil chemoattractant when injected into the skin of a rhesus monkey. Radiolabeled eotaxin was used to identify a high affinity receptor on eosinophils (0.52 nM Kd), expressed at 4.8 x 10(4) sites per cell. This receptor also bound RANTES and monocyte chemotactic protein-3 with lower affinity, but not macrophage inflammatory protein-1 alpha. Eotaxin could desensitize calcium responses of eosinophils to RANTES and monocyte chemotactic protein-3, although RANTES was able to only partially desensitize eosinophil calcium responses to eotaxin. Immunohistochemistry on human nasal polyp with antieotaxin mAbs showed that certain leukocytes as well as respiratory epithelium were intensely immunoreactive, and eosinophil infiltration occurred at sites of eotaxin upregulation. Thus eotaxin in humans is a potent and selective eosinophil chemoattractant that is expressed by a variety cell types in certain inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609214      PMCID: PMC507095          DOI: 10.1172/JCI118456

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.

Authors:  B Moser; C Schumacher; V von Tscharner; I Clark-Lewis; M Baggiolini
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

2.  Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type.

Authors:  N J Skelton; F Aspiras; J Ogez; T J Schall
Journal:  Biochemistry       Date:  1995-04-25       Impact factor: 3.162

Review 3.  Chemokines, leukocyte trafficking, and inflammation.

Authors:  T J Schall; K B Bacon
Journal:  Curr Opin Immunol       Date:  1994-12       Impact factor: 7.486

4.  Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.

Authors:  I Clark-Lewis; B Moser; A Walz; M Baggiolini; G J Scott; R Aebersold
Journal:  Biochemistry       Date:  1991-03-26       Impact factor: 3.162

5.  Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs.

Authors:  P J Jose; I M Adcock; D A Griffiths-Johnson; N Berkman; T N Wells; T J Williams; C A Power
Journal:  Biochem Biophys Res Commun       Date:  1994-11-30       Impact factor: 3.575

6.  Fibroblasts, mononuclear phagocytes, and endothelial cells express monocyte chemoattractant protein-1 (MCP-1) in inflamed human gingiva.

Authors:  X Yu; D T Graves
Journal:  J Periodontol       Date:  1995-01       Impact factor: 6.993

7.  Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues.

Authors:  J H Gong; I Clark-Lewis
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

8.  Cloning and functional expression of a human eosinophil CC chemokine receptor.

Authors:  C Combadiere; S K Ahuja; P M Murphy
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

9.  Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo.

Authors:  P D Collins; S Marleau; D A Griffiths-Johnson; P J Jose; T J Williams
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

10.  CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration.

Authors:  T H Rand; W W Cruikshank; D M Center; P F Weller
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

View more
  151 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Protective effect of eotaxin-2 inhibition in adjuvant-induced arthritis.

Authors:  J N Ablin; M Entin-Meer; V Aloush; S Oren; O Elkayam; J George; I Barshack
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

3.  High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.

Authors:  M Uguccioni; C R Mackay; B Ochensberger; P Loetscher; S Rhis; G J LaRosa; P Rao; P D Ponath; M Baggiolini; C A Dahinden
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Macrophage inflammatory protein 3alpha-CC chemokine receptor 6 interactions play an important role in CD4+ T-cell accumulation in periodontal diseased tissue.

Authors:  Y Hosokawa; T Nakanishi; D Yamaguchi; K Takahashi; H Yumoto; K Ozaki; T Matsuo
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

Review 5.  Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies.

Authors:  Manuel A R Ferreira
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

6.  Association between three single nucleotide polymorphisms in eotaxin (CCL 11) gene, hexanucleotide repetition upstream, severity and course of coronary atherosclerosis.

Authors:  J Máchal; A Vašků; V Kincl; M Hlavna; V Bartáková; M Jurajda; J Meluzín
Journal:  J Appl Genet       Date:  2012-07-07       Impact factor: 3.240

7.  Eotaxin expression in Sephadex-induced lung injury in rats.

Authors:  R F Guo; P A Ward; J A Jordan; M Huber-Lang; R L Warner; M M Shi
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 8.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

9.  Association of eotaxin-2 gene polymorphisms with plasma eotaxin-2 concentration.

Authors:  Ji-Won Min; June-Hyuk Lee; Choon-Sik Park; Hun Soo Chang; Tai Youn Rhim; Sung-Woo Park; An-Soo Jang; Hyoung-Doo Shin
Journal:  J Hum Genet       Date:  2005-03-03       Impact factor: 3.172

10.  Eotaxin increases monolayer permeability of human coronary artery endothelial cells.

Authors:  Md Saha Jamaluddin; Xinwen Wang; Hao Wang; Cubas Rafael; Qizhi Yao; Changyi Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-24       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.